Cargando…

Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients

Hyponatremia is an electrolyte disorder frequently observed in several clinical settings and common in hospitalized patients with decompensated heart failure (HF). It is caused by deregulation of arginine vasopressin (AVP) homeostasis associated with water retention in hypervolemic or in euvolemic s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nodari, Savina, Jao, Geoffrey T, Chiong, Jun R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108784/ https://www.ncbi.nlm.nih.gov/pubmed/21694929

Ejemplares similares

Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011)

Renoprotection by long‐term low‐dose tolvaptan in patients with heart failure and hyponatremia
por: Oka, Tatsufumi, et al.
Publicado: (2021)

Tolvaptan and its potential in the treatment of hyponatremia
por: Dixon, Megan B, et al.
Publicado: (2008)

Management of hyponatremia associated with acute porphyria—proposal for the use of tolvaptan
por: Solares, Isabel, et al.
Publicado: (2020)

Effect of tolvaptan on acute heart failure with hyponatremia – A randomized, double blind, controlled clinical trial
por: Shanmugam, Elangovan, et al.
Publicado: (2016)

Current Management of Hyponatremia in Acute Heart Failure: A Report From the Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (HN Registry)
por: Dunlap, Mark E., et al.
Publicado: (2017)

SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan
por: De las Peñas, Ramón, et al.
Publicado: (2015)

Tolvaptan vs. furosemide‐based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA‐AHF)
por: Ng, Tien M.H., et al.
Publicado: (2020)

Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016)

Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives
por: Thajudeen, Bijin, et al.
Publicado: (2016)

Tolvaptan for hyponatremia with preserved sodium pool in critically ill patients
por: Umbrello, Michele, et al.
Publicado: (2016)

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
por: Wang, Shuzhen, et al.
Publicado: (2018)

Management of Hyponatremia in Heart Failure: Practical Considerations
por: Şorodoc, Victoriţa, et al.
Publicado: (2023)

Hemodynamic and Hormonal Effects of Tolvaptan for Heart Failure
por: Kiuchi, Shunsuke, et al.
Publicado: (2018)

Clinical utility of early use of tolvaptan in very elderly patients with acute decompensated heart failure
por: Niikura, Hiroki, et al.
Publicado: (2017)

Edematous Hyponatremia Treated with Tolvaptan in a Patient with Amyotrophic Lateral Sclerosis
por: Kim, Gheun-Ho
Publicado: (2017)

Tolvaptan in the Treatment of Acute Hyponatremia Associated with Acute Kidney Injury
por: Gopinath, Shilpa, et al.
Publicado: (2013)

Hyponatremia in Heart Failure: Pathogenesis and Management
por: Rodriguez, Mario, et al.
Publicado: (2019)

Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone
por: Han, Sang Woong, et al.
Publicado: (2018)

A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan
por: Petereit, Claudia, et al.
Publicado: (2013)

Hyponatremia in Cirrhosis and End-Stage Liver Disease: Treatment with the Vasopressin V(2)-Receptor Antagonist Tolvaptan
por: Gaglio, Paul, et al.
Publicado: (2012)

Unpredictable Nature of Tolvaptan in Treatment of Hypervolemic Hyponatremia: Case Review on Role of Vaptans
por: Malhotra, Ishan, et al.
Publicado: (2014)

Effect of tolvaptan on hyponatremia in a dog with syndrome of inappropriate secretion of antidiuretic hormone
por: YAMAMOTO, Hiroka, et al.
Publicado: (2023)

Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis
por: Indirli, Rita, et al.
Publicado: (2021)

Long-Term Tolvaptan Treatment in Refractory Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2019)

Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome
por: Aghel, Arash, et al.
Publicado: (2008)

Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia
por: Hayashi, Manabu, et al.
Publicado: (2018)

The role of tolvaptan in managing hyponatremia in small cell lung cancer patients with SIADH: a retrospective study of 23 cases
por: Ren, Peng, et al.
Publicado: (2021)

Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta‐analysis
por: Shang, Wenli, et al.
Publicado: (2022)

Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
por: Katsumata, Mari, et al.
Publicado: (2017)

Renoprotective effect of tolvaptan in patients with new‐onset acute heart failure
por: Kin, Hiromi, et al.
Publicado: (2020)

Predictors of in-hospital mortality in elderly patients with heart failure treated with tolvaptan
por: Kobayashi, Masakazu, et al.
Publicado: (2023)

Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study
por: Estilo, Alvin, et al.
Publicado: (2021)

Temporal Change in Renoprotective Effect of Tolvaptan on Patients with Heart Failure: AURORA Study
por: Nishino, Masami, et al.
Publicado: (2022)

Tolvaptan for water retention in heart failure: a systematic review
por: Pan, Yujing, et al.
Publicado: (2023)

A prospective study to compare the clinical efficacy of Tolvaptan with 3% hypertonic saline solution in hospitalized patients having hyponatremia
por: Vilapurathu, Jobin Kunjumon, et al.
Publicado: (2014)

Tolvaptan
por: Rangarajan, Bharath, et al.
Publicado: (2014)

Effects of door‐to‐tolvaptan time on short‐term clinical outcome in patients with acute heart failure
por: Nomura, Ryohei, et al.
Publicado: (2023)

Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic‐refractory congestive heart failure: the SEMI‐SEC project
por: Pose, Antonio, et al.
Publicado: (2017)

Low-Dose Tolvaptan for the Treatment of Dilutional Hyponatremia in Cirrhosis: A Case Report and Literature Review
por: Shen, Guo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4g6dmnp0efv569id84otoeqork